Journal
eBioMedicine
Publication Date
12-1-2024
Volume
110
First Page
105431
Document Type
Open Access Publication
DOI
10.1016/j.ebiom.2024.105431
Rights and Permissions
Farooq H, Luehmann HP, Koenitzer JR, Heo GS, Sultan DH, Kulkarni DH, Gunsten SP, Sashti RM, Huang T, Keller AR, Lavine KJ, Atkinson JJ, Wingler LM, Liu Y, Brody SL. Molecular imaging in experimental pulmonary fibrosis reveals that nintedanib unexpectedly modulates CCR2 immune cell infiltration. EBioMedicine. 2024 Dec;110:105431. doi: 10.1016/j.ebiom.2024.105431. © 2024 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Recommended Citation
Farooq, Hasan; Luehmann, Hannah P; Koenitzer, Jeffrey R; Heo, Gyu Seong; Sultan, Deborah H; Kulkarni, Devesha H; Gunsten, Sean P; Sashti, Rekha M; Huang, Tao; Keller, Amanda R; Lavine, Kory J; Atkinson, Jeffrey J; Wingler, Laura M; Liu, Yongjian; and Brody, Steven L, "Molecular imaging in experimental pulmonary fibrosis reveals that nintedanib unexpectedly modulates CCR2 immune cell infiltration." eBioMedicine. 110, 105431 (2024).
https://digitalcommons.wustl.edu/oa_4/5493
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
